Painchart, Claire <br/><br/>
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.  [electronic resource] 

 -  Digestive diseases and sciences  05 2020 
 - 1445-1452 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-019-05865-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers--blood<br/>Crohn Disease--blood<br/>Female<br/>Humans<br/>Induction Chemotherapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Reference Values<br/>Treatment Outcome<br/>Ustekinumab--blood